Keith W. Pratz

Sidney Kimmel Comprehensive Cancer Center

Also affiliated with University of Pennsylvania

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults”.

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Blood Advances(2020)10.1182/bloodadvances.2020002945

N/A

0DataRank · unranked

31 citations

Leo Luznik, Hua-Ling Tsai, Philip Imus, Amy E. DeZern, Keith W. Pratz +21 more

CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia

Cancer Research(2021)10.1158/0008-5472.can-20-1504

N/A

0DataRank · unranked

9 citations

Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam +16 more

Recent advances in targeted therapies in acute myeloid leukemia

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01424-6

N/A

0DataRank · unranked

268 citations

Keith W. Pratz, Catherine Lai, Rahul S. Bhansali

Data from CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia

(2023)10.1158/0008-5472.c.6512716.v1

N/A

0DataRank · unranked

0 citations

Nicole D. Vincelette, Cordelia D. McGehee, Mira A. Kohorst, Brian D. Koh, Annapoorna Venkatachalam +16 more

Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.062

N/A

0DataRank · unranked

17 citations

Thuy T. Koll, Shannon Gier, Alessandro Racioppi, Griffin White, M. Lew +22 more

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

Haematologica(2024)10.3324/haematol.2024.285275

N/A

0DataRank · unranked

2 citations

Neeharika Prathapa, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Ximena Bruno +13 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Evolving racial/ethnic disparities in AML survival in the novel therapy era

Blood Advances(2025)10.1182/bloodadvances.2024014127

N/A

0DataRank · unranked

14 citations

Phyllis A. Gimotty, Andrew Matthews, Ronac Mamtani, Selina M. Luger, Elizabeth O. Hexner +15 more